Titre Long Term Follow-Up of Participants Exposed to GSK3377794 (NY-ESO-1c259 T), a Genetically Engineered NY-ESO-1 Specific T Cell Receptor
Protocole ID GSK 208750
ClinicalTrials.gov ID NCT03391778
Type(s) de cancer Autre
Phase Autres
Institution CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL  
Ville Montréal
Investigateur(trice) principal(e) Dr Simon Turcotte
Coordonnateur(trice) Marie Martin
514-890-8000 poste 30737
Statut Actif en recrutement
Critètes d'éligibilité
  • Subjects who have received at least one dose of GSK3377794 in the interventional study.
  • Subjects who have either completed the interventional study or have withdrawn from it.
  • Male or Female subjects.
  • Capable of giving signed informed consent prior to the study participation.
Critètes d'exclusion
  •  None